Ropes & Gray advised Pfizer Inc. on its definitive agreement to acquire Hospira, the Lake Forest, Ill.-based leading provider of injectable drugs and infusion technologies and a worldwide leader in biosimilars, for a total value of approximately $17 billion. The deal was announced Feb. 5 and is expected to close in the second half of 2015.
Securities & public companies partners Marko Zatylny and Paul Kinsella led the Ropes & Gray team advising Pfizer on the transaction.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.